Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H1EB
|
||||
Former ID |
DIB018908
|
||||
Drug Name |
ATLa2
|
||||
Synonyms |
ATL analog [15-epi-16-(para-fluoro)-phenoxy-LXA4]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540331] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H29FO5
|
||||
InChI |
InChI=1S/C23H29FO5/c1-18(17-29-20-15-13-19(24)14-16-20)9-6-4-2-3-5-7-10-21(25)22(26)11-8-12-23(27)28/h2-7,9-10,13-16,18,21-22,25-26H,8,11-12,17H2,1H3,(H,27,28)/b4-2-,5-3+,9-6+,10-7+/t18-,21+,22-/m0/s1
|
||||
InChIKey |
SGFIFYSIHRWSCE-LLXPRBAESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | FMLP-related receptor I | Target Info | Agonist | [527021] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.